289 related articles for article (PubMed ID: 25389387)
1. The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.
Ouzzine M; Gulberti S; Ramalanjaona N; Magdalou J; Fournel-Gigleux S
Front Cell Neurosci; 2014; 8():349. PubMed ID: 25389387
[TBL] [Abstract][Full Text] [Related]
2. Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.
Fujiwara R; Yokoi T; Nakajima M
Front Pharmacol; 2016; 7():388. PubMed ID: 27822186
[TBL] [Abstract][Full Text] [Related]
3. [UDP-glucuronyltransferases in detoxification and activation metabolism of endogenous compounds and xenobiotics].
Fedejko B; Mazerska Z
Postepy Biochem; 2011; 57(1):49-62. PubMed ID: 21735820
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes.
Kuehl GE; Bigler J; Potter JD; Lampe JW
Drug Metab Dispos; 2006 Feb; 34(2):199-202. PubMed ID: 16258079
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation.
Burchell B
Am J Pharmacogenomics; 2003; 3(1):37-52. PubMed ID: 12562215
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of Drug Glucuronide Metabolites in the Budding Yeast Saccharomyces cerevisiae.
Ikushiro S; Nishikawa M; Masuyama Y; Shouji T; Fujii M; Hamada M; Nakajima N; Finel M; Yasuda K; Kamakura M; Sakaki T
Mol Pharm; 2016 Jul; 13(7):2274-82. PubMed ID: 27241161
[TBL] [Abstract][Full Text] [Related]
7. Natural and synthetic inhibitors of UDP-glucuronosyltransferase.
Grancharov K; Naydenova Z; Lozeva S; Golovinsky E
Pharmacol Ther; 2001 Feb; 89(2):171-86. PubMed ID: 11316519
[TBL] [Abstract][Full Text] [Related]
8. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years.
Radominska-Pandya A; Bratton S; Little JM
Curr Drug Metab; 2005 Apr; 6(2):141-60. PubMed ID: 15853765
[TBL] [Abstract][Full Text] [Related]
9. Human UDP-glucuronosyltransferase 2B7.
Radominska-Pandya A; Little JM; Czernik PJ
Curr Drug Metab; 2001 Sep; 2(3):283-98. PubMed ID: 11513331
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.
Sakaguchi K; Green M; Stock N; Reger TS; Zunic J; King C
Arch Biochem Biophys; 2004 Apr; 424(2):219-25. PubMed ID: 15047194
[TBL] [Abstract][Full Text] [Related]
11. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.
Rowland A; Miners JO; Mackenzie PI
Int J Biochem Cell Biol; 2013 Jun; 45(6):1121-32. PubMed ID: 23500526
[TBL] [Abstract][Full Text] [Related]
12. UDP-glucuronosyltransferases (UGTs) in neuro-olfactory tissues: expression, regulation, and function.
Heydel JM; Holsztynska EJ; Legendre A; Thiebaud N; Artur Y; Le Bon AM
Drug Metab Rev; 2010 Feb; 42(1):74-97. PubMed ID: 20067364
[TBL] [Abstract][Full Text] [Related]
13. UDP-glucuronosyltransferases.
King CD; Rios GR; Green MD; Tephly TR
Curr Drug Metab; 2000 Sep; 1(2):143-61. PubMed ID: 11465080
[TBL] [Abstract][Full Text] [Related]
14. Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Tukey RH; Strassburg CP
Annu Rev Pharmacol Toxicol; 2000; 40():581-616. PubMed ID: 10836148
[TBL] [Abstract][Full Text] [Related]
15. [Glucuronidation of antitumour therapeutics--detoxification, mechanism of resistance or prodrug formation?].
Mróz A; Mazerska Z
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1462-77. PubMed ID: 27259218
[TBL] [Abstract][Full Text] [Related]
16. Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions.
Bock KW; Köhle C
Biochem Pharmacol; 2009 May; 77(9):1458-65. PubMed ID: 19150343
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7.
Seo KA; Bae SK; Choi YK; Choi CS; Liu KH; Shin JG
Drug Metab Dispos; 2010 Nov; 38(11):2007-13. PubMed ID: 20713656
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional studies of UDP-glucuronosyltransferases.
Radominska-Pandya A; Czernik PJ; Little JM; Battaglia E; Mackenzie PI
Drug Metab Rev; 1999 Nov; 31(4):817-99. PubMed ID: 10575553
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.
Green MD; Tephly TR
Drug Metab Dispos; 1998 Sep; 26(9):860-7. PubMed ID: 9733664
[TBL] [Abstract][Full Text] [Related]
20. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
